OptiBiotix Health (LON:OPTI) Stock Price Up 5.4% – What’s Next?

OptiBiotix Health Plc (LON:OPTI) traded up 5.4% during trading on Monday . The stock traded as high as GBX 8.50 and last traded at GBX 8.33. 241,136 shares were traded during mid-day trading, a decline of 13% from the average session volume of 277,224 shares. The stock had previously closed at GBX 7.90.

OptiBiotix Health Stock Down 1.3%

The stock has a market cap of £8.06 million, a P/E ratio of -260.00 and a beta of 1.71. The firm has a 50 day moving average price of GBX 9.30 and a 200 day moving average price of GBX 11.58.

OptiBiotix Health (LON:OPTI) last released its earnings results on Tuesday, September 16th. The company reported GBX (1.15) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative return on equity of 36.76% and a negative net margin of 524.43%.

Insiders Place Their Bets

In other news, insider David Blain bought 84,053 shares of the company’s stock in a transaction that occurred on Wednesday, October 1st. The stock was bought at an average price of GBX 1,175 per share, with a total value of £987,622.75. Also, insider Stephen O’Hara purchased 95,238 shares of the business’s stock in a transaction on Tuesday, September 23rd. The stock was acquired at an average price of GBX 11 per share, with a total value of £10,476.18. Over the last three months, insiders bought 229,291 shares of company stock valued at $100,309,893. Corporate insiders own 26.82% of the company’s stock.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.